Publications of A. Leonov

Conference Paper (6)

41.
Conference Paper
Prix, C.; Schmidt, F.; Levin, J.; Schinke, K.; Shi, S.; Ryazanov, S.; Leonov, A.; Högen, T.; Mitteregger-Kretzschmar, G.; Kretzschmar, H. A. et al.; Bötzel, K.; Griesinger, C.; Giese, A.: The oligomer modulator anle138b is effective in the prodromal phase of a transgenic mouse model of Parkinson's disease. Joint Congress of European Neurology, Istanbul, Turkey, May 31, 2014 - June 03, 2014. European Journal of Neurology 21 (Suppl. 1), p. 170 - 170 (2014)
42.
Conference Paper
Kretzschmar, H.; Wagner, J.; Ryazanov, S.; Leonov, A.; Levin, J.; Shi, S.; Prix, C.; Groschup, M.; Griesinger, C.; Giese, A.: Causal therapy of prion and Parkinson's disease with novel inhibitors of protein aggregation. 87th Annual Meeting of the American Association of Neuropathologists, Seattle, WA, June 23, 2011 - June 26, 2011. Journal of Neuropathology and Experimental Neurology 70 (6), p. 505 - 505 (2011)
43.
Conference Paper
Levin, J.; Wagner, J.; Ryazanov, S.; Leonov, A.; Shi, S.; Schmidt, F.; Prix, C.; Bertsch, U.; Mitteregger-Kretzschmar, G.; Geissen, M. et al.; Hischberger, T.; Tavan, P.; Pilger, J.; Zweckstetter, M.; Frank, T.; Baehr, M.; Weishaupt, J.; Uhr, M.; Urlaub, H.; Teichmann, U.; Boetzel, K.; Groschup, M.; Kretzschmar, H. A.; Griesinger, C.; Giese, A.: Causal therapy of Parkinson's disease with anle138b, a novel protein aggregation inhibitor. 15th International Congress of Parkinsons Disease and Movement Disorders, Toronto, CANADA, 2011. Movement Disorders 26 (Supplement 2), p. S21 - S21 (2011)

Patent (1)

44.
Patent
Giese, A.; Bertsch, U.; Kretzschmar, H.; Habeck, M.; Hirschberger, T.; Tavan, P.; Griesinger, C.; Leonov, A.; Ryazanov, S.; Weber, P.: New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases. WO/2010/00372 (2010)
Go to Editor View